ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference
ResMed (NYSE: RMD) announced that Rob Douglas, its president and COO, will present at the William Blair Growth Stock Conference on June 8, 2022, at 9:20 a.m. CDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ResMed (NYSE: RMD) announced that Rob Douglas, its president and COO, will present at the William Blair Growth Stock Conference on June 8, 2022, at 9:20 a.m. CDT. The event will take place at the Loews Chicago Hotel, and investors can access more information and a live webcast through ResMed's investor site. A replay will be available approximately 12 hours after the event until September 6, 2022. ResMed focuses on innovative health solutions for chronic diseases, aiming to improve healthcare quality and reduce costs globally.
Positive
- Upcoming presentation by leadership may boost investor confidence.
- Focus on digital health technologies and chronic disease management aligns with market trends.
Negative
- None.
Details
News Market Reaction – RMD
The recorded move for RMD in the trading session of this news was -0.37%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the William Blair Growth Stock Conference on Wednesday, June 8, 2022, beginning at approximately 9:20 a.m. (Central Daylight Time) at the Loews Chicago Hotel in Chicago.
More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 12 hours after the live webcast ends and will be accessible through September 6, 2022.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 858.836.6798 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.